| MAGALLANES VALUE INVESTORS UCITS-EUROPEAN EQUITY-P | RVI EUROPA | 19,72% | 53,75% | 80,23% | 184,58% |
| JPM GLOBAL GROWTH C (ACC) USD | RVI GLOBAL CRECIMIENTO | 3,13% | 59,04% | 22,94% | 184,45% |
| ELEVA UCITS FUND - ELEVA EUROPEAN SELECTION FUND I (EUR) ACC | RVI EUROPA | 11,23% | 57,91% | 52,57% | 184,41% |
| GOLDMAN SACHS EUROZONE EQUITY INCOME I CAP EUR | RV EURO VALOR | 18,46% | 61,04% | 71,22% | 184,40% |
| HARRIS ASSOCIATES U.S. VALUE EQUITY H-N/A (EUR) | RVI USA VALOR | 17,40% | 51,88% | 43,12% | 184,40% |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | RVI BIOTECNOLOGÍA | 42,78% | 80,79% | 53,59% | 184,37% |
| BGF US MID-CAP VALUE D2 USD | RVI USA SMALL/MID CAP | 24,62% | 49,19% | 57,47% | 184,24% |
| VANGUARD ESG DEVELOPED WORLD ALL CAP EQUITY INDEX GENERAL GBP DIS | RVI GLOBAL | 16,16% | 64,99% | 49,41% | 184,22% |
| BRANDES EUROPEAN VALUE FUND I GBP CAP | RVI EUROPA VALOR | 25,98% | 90,41% | 108,90% | 184,13% |
| PARTNERS GROUP LISTED INVESTMENTS SICAV - LISTED PRIVATE EQUITY USD P ACC | RVI GLOBAL | -3,50% | 36,68% | 8,31% | 184,10% |
